✦ On March 9, global insurance brokerage firm Aon PLC agreed to buy fellow broker Willis Towers Watson in a deal that values the new firm at roughly $80 billion, according to a joint press release. The release emphasized the technology-driven nature of the deal and claimed the transaction will generate $10 billion in shareholder value. Companies like Aon and Willis Towers Watson help employers choose health plans and PBMs for their workers. Both firms’ stocks, which have trended downward since February, rallied the day after the announcement, but declined severely in subsequent days as markets crashed in response to an onslaught of bad COVID-19 news. Read the release at https://bit.ly/2QccPYS.
✦ CMS on March 11 rolled out a voluntary model that would set out-of-pocket costs for insulin at a maximum $35 copayment per 30-day supply throughout the benefit year for beneficiaries in participating enhanced Part D plans. The goal is to ensure that beneficiaries in participating plans “will have predictable copays for a broad set of formulary insulins, including rapid-acting, short-acting, intermediate-acting, and long-acting insulins, marketed by participating manufacturers from the beginning of the plan year and through the coverage gap phase,” according to a press release. Visit https://go.cms.gov/39Kn1zx.